GeneGo

Overview

GeneGo provides biology and disease information, analytics, and decision support solutions for pharmaceutical research and development. It offers MetaBase, a database for systems biology. MetaBase is the knowledge base behind the platform that includes MetaCore and MetaDrug, and is delivered as an Oracle database with more than 200 tables; Meta Miner - oncology platform; MetaDiscovery - platform whcih allows integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks; MetaCore 6.2 - sollution to assist pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology; MetaDrug 6.2 - a solution designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. It also offers analytics, data management, and value-added services. It assists in biomarker discovery & patient stratification, target identification, drug resistance and sensitivity, drug repositioning, drug combination discovery, and pharmacology and toxicity assessmentIt was acquired by Thomson Reuters in Nov 2010 and became a part of Healthcare & Science business of Thomson Reuters.

Key facts

Founded

2000

Headquarters

San Diego, United States

Stage

Xxxxxx XSign up to view

Industry

Life Sciences Technology